For the final quarter of 2024, the fund gained 1.08%, trailing the 2.41% advance of the benchmark S&P 500® index. Read more ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its ...

Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival ...

For the three months ending December 31, 2024, the fund's Retail Class shares gained 1.53%, versus the 2.41% result of the ...

Hims & Hers Health ( HIMS -12.79%) stock took a tumble Thursday morning, falling 9.2% through 11:40 a.m. ET on some ...

Novo Nordisk has announced the launch of NovoCare Pharmacy, a new initiative that will offer its weight-loss drug Wegovy ...

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

(Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli ...

Cambridge synthetic biology doyen Constructive Bio has been awarded a significant grant from Innovate UK to transform the ...